Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients

Hansen, Rikke P; Vedsted, Peter; Sokolowski, Ineta; Søndergaard, Jens; Olesen, Frede

doi:10.1186/1472-6963-11-284

BMC Health Services Research

Table 2 Delay (in days) for all and the 10 most frequent cancers in the study when the GP was involved in the diagnostic investigation process

From: Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients

										System delay
	Total delay			Patient delay			GP delay									System delay in secondary health care									System delay in secondary health care (GP not involved)
										Total system delay			System delay in primary health care			System delay in secondary health care			Diagnostic delay in secondary health care			Treatment delay
Cancer type (Cancer cases, GP involved/Cancer cases, GP not involved)	N	Median	IQI*	N	Median	IQI	N	Median	IQI	N	Median	IQI	N	Median	IQI	N	Median	IQI	N	Median	IQI	N	Median	IQI	N	Median	IQI
All cancers (1892/320)	936	98	57-168	1237	21	7-56	1877	0	0-2	1422	55	32-93	1874	0	0-12	1412	46	26-78	1823	29	14-57	1403	14	0-28	174	37	17-63
Breast cancer (291/20)	159	65	39-106	168	14	0-56	289	0	0-0	269	40	25-59	287	0	0-0	268	37	22-51	281	21	13-36	266	12	4-20	10	29	23-38
Colorectal cancer (254/37)	159	109	65-194	187	28	14-56	254	0	0-6	212	56	34-87	254	0	0-10	216	48	28-71	251	30	15-50	215	14	0-28	24	15	3-30
Lung cancer (253/75)	128	108	82-167	182	28	7-56	251	0	0-9	182	69	47-96	250	7	0-18	181	55	36-79	246	27	14-46	182	23	8-36	40	51	27-76
Prostate cancer (190/24)	73	130	89-254	110	28	0-112	186	0	0-6	117	102	55-151	187	6	0-18	115	75	44-135	183	80	44-110	114	9	0-29	16	83	48-139
Melanoma (122/9)	38	114	79-279	40	70	28-196	122	0	0-0	114	39	22-65	122	0	0-15	112	27	15-54	117	20	0-42	110	13	0-23	1	49
Bladder cancer (73/7)	32	134	93-181	52	14	0-28	72	0	0-10	43	91	52-119	71	2	0-19	42	80	45-113	68	62	35-87	43	0	0-20	4	51	22-75
Non-Hodgkin's lymphoma (54/11)	29	78	58-118	43	21	7-42	53	0	0-3	34	60	44-86	54	2	0-14	34	55	39-73	51	36	14-68	34	12	5-29	4	38	33-51
Pancreas cancer (54/9)	21	87	49-153	40	14	7-42	53	0	0-6	28	63	27-117	54	0	0-15	28	59	25-91	51	27	11-68	27	14	0-41	5	15	10-50
Ovarian cancer (47/12)	32	60	45-112	38	21	0-35	47	0	0-2	40	30	21-49	47	0	0-8	40	26	20-43	45	21	12-31	39	1	0-21	9	40	20-62
Corpus uteri cancer (41/6)	35	99	51-22	35	21	0-140	41	0	0-0	41	64	41-106	41	0	0-1	41	60	32-101	39	38	23-79	39	7	0-14	3	59	28-77
Others (513/110)	233	96	56-178	342	21	7-56	509	0	0-6	338	63	35-110	507	0	0-11	335	52	29-93	491	27	12-55	334	17	0-34	58	32	13-62

N in each column is the number of answers with complete data. Last column shows system delay in secondary health care when the GP was not involved in the diagnostic investigation process
*IQI = interquartile interval

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com